DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2382be/hot_topics_in_type) has announced the addition of the "Hot Topics in Type 2 Diabetes: Physician Perceptions of Insulin - Physician survey provides insights into insulin usage and needs" report to their offering.
Insulin prescribing practices and physician perception of unmet needs vary widely among the seven major markets. Datamonitor surveyed 199 primary care physicians and specialists across these markets on their type 2 diabetes treatment choices and prescribing behavior.
Features and Benefits:
- Analyze country-specific physician insulin use by therapy line and insulin class.
- Compare physician-reported trends in insulin use by class.
- Use key opinion leader insight to explain reported trends and unmet needs in the insulin market.
- Identify opportunities for insulin and non-insulin therapies to target underserved markets and physician cohorts.
Highlights:
- Physicians report using insulin therapy in over one-third of patients in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). Insulins are predominantly used at third-line therapy and later, and as part of combination treatment regimes. Physicians expect their use of insulin to increase in the future.
- Insulin use varies significantly between markets, from a low of 22% patient share in France and the UK, where oral drugs are preferred, to 43% of patients at using insulin at the current time, in Germany. Markets with higher use also have earlier initiation of insulin.
- Basal insulins and prandial insulin, particularly the analogs, have come to dominate insulin therapy in recent times. Lantus dominates basal insulin use, on the basis of its concentration profile in the body. However, little difference is perceived between the insulin options, and individual patient response is a major factor.
Your Key Questions Answered:
- Delve into primary data from 199 seven major market physicians on present insulin usage and trends.
- Use key opinion leader insight to elucidate differences in prescribing practices among the major markets.
- Identify unmet needs in insulin therapy and opportunities in the type 2 diabetes treatment algorithm.
Key Topics Covered:
Overview
- Catalyst
- Summary
Methodology
- Insulins in the treatment algorithm
- Benefits and shortcomings of this survey method
Insulins in the Type 2 Diabetes Treatment Algorithm
- Overall insulin use
- Insulin market share varies widely in different markets
- Insulins used mainly as later-line therapy
- Insulin use by class
- Class comparison: basal insulins take major share of insulin-treated patients
- Basal insulins
- Prandial insulins
- Intermediate-acting insulins
- Premixed insulins
- Brand share in key classes
- Basal insulin use by brand
- Prandial insulin use by brand
Insulin Prescribing Practices and Unmet Needs
- Trends in insulin use
- Insulin use is growing across the seven major markets
- Analog insulin use grows at the expense of older classes
- Initiation of insulin therapy
- Indications for insulin use in type 2 diabetes
- Insulin and other drugs: physicians see metformin as leading combination option
- Time to initiation of insulin therapy
- HbA1c and insulin treatment
- Referral to a specialist
- Patient compliance with insulin treatment
- Unmet needs in insulin therapy
- Conclusions
Bibliography
- Journal papers
- Online sources
Appendix
- Datamonitor's type 2 diabetes physician survey
- Contributing experts
- Report methodology
For more information visit http://www.researchandmarkets.com/research/2382be/hot_topics_in_type
Source: Datamonitor